Suppression of Human Anti-Mouse Antibody Response to Murine Monoclonal Antibody L6 by Deoxyspergualin: A Phase I Study
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 353, 193-202
- https://doi.org/10.1007/978-1-4615-2443-4_18
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Drug Targeting with Monoclonal Antibodies: A reviewActa Oncologica, 1992
- 15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 miceInflammation Research, 1991
- Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cellsImmunology & Cell Biology, 1991
- Development of human anti‐murine antibody (HAMA) response in patientsImmunology & Cell Biology, 1990
- A NOVEL RESCUE DRUG, 15-DEOXYSPERGUALINTransplantation, 1990
- Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant diseasesNuclear Medicine Communications, 1988
- ANTI-IDIOTYPIC AND NON-ANTI-INDIOTYPIC ANTIBODIES TO OKT3 ARISING DESPITE INTENSE IMMUNOSUPPRESSIONTransplantation, 1986
- EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTIONTransplantation, 1984
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975